SCHEMBL1742671

SCHEMBL1742671

O=S(=O)(Cl)c1ccsc1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 2/20 0.38
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6828432 0.80 CA2 (0.39) LMNA
SCHEMBL27449562 0.71
SCHEMBL384644 0.70 TRPV4 (0.38) TRPV4LMNAMEN1KMT2A
SCHEMBL5559189 0.70 LMNA (0.33) TRPV4LMNAMEN1KMT2A
SCHEMBL2802756 0.68 HTR6 (0.45) TRPV4LMNAMEN1KMT2A
SCHEMBL11484963 0.68 LMNA (0.36) TRPV4LMNAMEN1KMT2A
SCHEMBL1035114 0.68 LMNA (0.32) LMNAMEN1KMT2A
SCHEMBL8735595 0.68
SCHEMBL16799844 0.67 CASP3 (0.36)
SCHEMBL15352797 0.64 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387559-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2011-11-23 EP disclosed